Consolidated statement of cash flows - BRL (R$) R$ in Thousands |
12 Months Ended |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
| Cash flows from operating activities |
|
|
|
| (Loss) profit before income taxes |
R$ (7,991,285)
|
R$ (5,245,119)
|
R$ 5,113,751
|
| Adjustments for: |
|
|
|
| Depreciation and amortization |
3,890,832
|
3,868,583
|
3,364,943
|
| Impairment |
1,493,752
|
3,155,400
|
|
| Impairment in associate |
|
4,672,396
|
|
| Interest in earnings (losses) of subsidiaries and associates |
(219,922)
|
(1,719,031)
|
(350,399)
|
| Interest in earnings (losses) of joint ventures |
10,885,023
|
1,229,980
|
(1,695,945)
|
| Loss (gain) on disposed assets |
99,324
|
(141,863)
|
17,016
|
| Share-based payment |
71,725
|
65,901
|
207,713
|
| Change in fair value of investment properties |
(1,441,276)
|
(1,273,033)
|
(2,259,924)
|
| Provision for legal proceedings |
333,659
|
313,876
|
204,158
|
| Interest, derivatives, monetary and foreign exchange, net |
9,789,736
|
10,217,952
|
9,379,506
|
| Sectorial financial assets and liabilities, net |
116,465
|
(37,061)
|
(110,125)
|
| Provisions for employee benefits |
465,482
|
454,930
|
419,241
|
| Allowance for expected credit losses |
44,478
|
52,839
|
74,706
|
| Profit on sale of investment |
(32,375)
|
383,205
|
|
| Revenue from insurance claims |
(940,596)
|
|
|
| Deferred income |
|
3,318
|
(597,998)
|
| Income from finance investments |
(9,143)
|
|
(1,284,647)
|
| Previously recognized gain in other comprehensive income reclassified to profit |
(206,388)
|
|
|
| Other |
(79,302)
|
(267,335)
|
245,043
|
| Cash flows from operating activities before changes in working capital |
16,270,189
|
15,734,938
|
12,727,039
|
| Variation in: |
|
|
|
| Trade receivable |
539,734
|
546,218
|
573,737
|
| Inventories |
(107,767)
|
159,667
|
(83,166)
|
| Other taxes, net |
(921,007)
|
(641,866)
|
(455,478)
|
| Income taxes paid |
(1,240,674)
|
(1,200,228)
|
(361,726)
|
| Related parties, net |
(128,327)
|
105,490
|
(188,798)
|
| Trade payables |
(246,613)
|
(180,867)
|
(252,810)
|
| Employee benefits |
(515,510)
|
(542,241)
|
(356,210)
|
| Provision for legal proceedings |
(319,801)
|
(305,324)
|
(461,574)
|
| Derivative financial instruments |
(48,773)
|
(9,192)
|
2,894
|
| Other financial liabilities |
75,083
|
(26,275)
|
(566,058)
|
| Judicial deposits |
(36,729)
|
(149,118)
|
(22,862)
|
| Post-employment benefit obligation |
(42,888)
|
(37,549)
|
(34,235)
|
| Other assets and liabilities, net |
(250,133)
|
(372,367)
|
(244,309)
|
| Changes in working capital |
(3,243,405)
|
(2,653,652)
|
(2,450,595)
|
| Net cash generated from operating activities |
13,026,784
|
13,081,286
|
10,276,444
|
| Cash flows from investing activities |
|
|
|
| Capital contribution to associates |
(15,678)
|
(29,997)
|
(47,300)
|
| Capital reduction in associates |
26,548
|
|
|
| Capital contribution in joint ventures |
|
(12,337)
|
|
| Acquisition of subsidiary, net of acquired cash |
(615,638)
|
(962,378)
|
(702,577)
|
| Sale (purchase) of marketable securities, net |
988,885
|
551,003
|
(507,976)
|
| Restricted cash |
(56,756)
|
42,012
|
(60,498)
|
| Dividends received from subsidiaries and associates |
107,424
|
1,018,794
|
254,905
|
| Dividends received from joint venture |
45,640
|
293,912
|
906,534
|
| Dividends received from finance investment |
87,608
|
|
1,305,410
|
| Other financial assets |
(134)
|
(621)
|
(7,485)
|
| Cash in the incorporation operation |
|
|
99,040
|
| Acquisition of property, plant and equipment, intangible and contract assets |
(8,459,867)
|
(7,834,521)
|
(6,267,962)
|
| Proceeds from the sale of investments |
8,945,294
|
2,725,625
|
645,772
|
| Related parties |
25,592
|
|
|
| Operation discontinued |
7,425
|
24,510
|
62,700
|
| Acquisition of subsidiary |
(251,706)
|
(17,047)
|
|
| Receipt of derivative financial instruments, except debt |
1,021
|
103,147
|
168,308
|
| Payment of derivative financial instruments, except debt |
(1,130,390)
|
(427,293)
|
(156,600)
|
| Cash received on the sale of fixed assets and intangible assets |
9,474
|
36,934
|
4,637
|
| Cash received of insurance compensation for loss of fixed asset |
209,186
|
|
|
| Net cash used in investing activities |
(76,072)
|
(4,488,257)
|
(4,303,092)
|
| Cash flows from financing activities |
|
|
|
| Proceeds from loans, borrowings and debentures |
11,546,508
|
16,983,225
|
12,785,628
|
| Principal repayment of loans, borrowings and debentures |
(14,293,953)
|
(12,187,560)
|
(8,054,763)
|
| Payment of interest on loans, borrowings and debentures |
(4,732,362)
|
(4,759,976)
|
(3,552,292)
|
| Payment of derivative financial instruments |
(2,841,877)
|
(2,860,601)
|
(2,851,267)
|
| Proceeds from derivative financial instruments |
1,019,179
|
1,144,473
|
1,193,534
|
| Costs of banking operations with derivatives |
|
(29,828)
|
(586,855)
|
| Principal repayment of leases |
(744,582)
|
(694,340)
|
(490,012)
|
| Payment of interest on leases |
(427,965)
|
(377,269)
|
(236,948)
|
| Capital increase |
10,280,240
|
|
|
| Capital reduction in associates |
(498,004)
|
(204,967)
|
(24,281)
|
| Payments to redeem entity’s shares and acquisition of treasury shares |
(34,022)
|
(192,915)
|
(103,283)
|
| Acquisition of non-controlling shareholders' shares- Cosan Nove |
(2,169,000)
|
|
|
| Acquisition of non-controlling shareholders’ shares - Cosan Dez |
(3,577,760)
|
|
|
| Dividends paid |
(1,698,703)
|
(2,779,081)
|
(2,582,447)
|
| Dividends paid for preferred shares |
(994,592)
|
(668,022)
|
|
| Gain on banking operations with derivatives |
22,100
|
20,993
|
|
| Cash received from financing secured by shares |
2,792,853
|
|
|
| Cash received from issuance of preferred shares of subsidiary |
4,000,000
|
|
|
| Payment of share-based compensation |
|
|
(13,597)
|
| Net cash used in financing activities |
(2,351,940)
|
(6,605,868)
|
(4,516,583)
|
| Increase in cash and cash equivalents |
10,598,772
|
1,987,161
|
1,456,769
|
| Cash and cash equivalents at the beginning of the year |
16,903,542
|
14,658,481
|
13,301,716
|
| Effect of the foreign exchange rate changes |
(258,631)
|
257,900
|
(100,004)
|
| Cash and cash equivalents at the end of the year |
R$ 27,243,683
|
R$ 16,903,542
|
R$ 14,658,481
|